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The Lewis-X (LeX) carbohydrate epitope, recognized by the FORSE-1 monoclonal antibody (mAb), shares expression
boundaries with neural regulatory genes and may be involved in patterning the neural tube by creating domains of
differential cell adhesion. The present experiments focus on the question of what determines the expression pattern of LeX
in embryonic rat brain. Comparisons of FORSE-1-positive glycolipid and protein antigens in embryonic, early postnatal, and
adult tissues show that the LeX epitope is carried primarily by glycolipids during embryonic development and by a
proteoglycan and glycoproteins in postnatal and adult tissue. Immunohistochemistry using FORSE-1 and an antibody to the
proteoglycan phosphacan, which carries LeX, shows that the distribution of LeX is more restricted than phosphacan. These
observations suggest that the precise spatial regulation of FORSE-1 binding in the embryonic forebrain is due to the
expression pattern of the LeX carbohydrate on glycolipids, rather than to the transcriptional regulation of a carrier
protein. © 1999 Academic Press
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During development of the central nervous system
(CNS), highly differentiated adult structures arise from a
relatively uniform neural tube. Prior to morphological dif-
ferentiation, subdivisions of the neural tube first become
distinguishable by differential patterns of transcription fac-
tor gene expression (Lumsden, 1990; Krumlauf et al., 1993;
Puelles and Rubenstein, 1993; Fishell, 1997). Cell surface
recognition molecules, downstream of transcription fac-
tors, may provide the basis for cell adhesion and axon guid-
ance both within and between these domains of regulatory
gene expression.
Lewis-X (LeX)-related oligosaccharides mediate low-
affinity adhesion and recognition events in the hematopoi-
etic system, via selectin receptors (Maly et al., 1996; Varki,
1 Present address: Ontogeny, Inc., 45 Moulton St., Cambridge,
MA 02138.
2 To whom correspondence should be addressed. Fax: (626) 585-
743. E-mail: php@caltech.edu.
2081994). Such carbohydrate-mediated recognition mecha-
nisms may also be involved in selective adhesion during
brain development, as is suggested by the inhibition of
selective sorting out of cells corresponding to different
brain regions in aggregate cultures by the addition of LeX
oligosaccharide (Go¨tz et al., 1996).
The FORSE-1 monoclonal antibody (mAb), which specifi-
cally labels the LeX epitope (Allendoerfer et al., 1995), was
obtained from a screen designed to generate mAbs against
surface antigens that might be regulated by regionally re-
stricted transcription factors (Tole et al., 1995). LeX is also
recognized by a number of mAbs in addition to FORSE-1,
including anti-CD15 (Mai and Scho¨nlau, 1992), 52G9 (Allen-
doerfer et al., 1995; Stainier et al., 1991), 7A (Yamamoto et al.,
1985), AC4 and DA3 (Dodd and Jessell, 1986), L5 (Streit et al.,
1996), and SSEA-1 (Gooi et al., 1981). Protein adhesion mol-
ecules have been shown to be downstream targets of ho-
meobox transcription factors (Chalepakis et al., 1994; Edel-
man and Jones, 1993), but a similar role for carbohydrate
recognition/adhesion molecules has been largely overlooked.
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209Lewis-X Patterning in Developing CNSBiochemical and immunohistochemical studies have re-
vealed a variety of carrier molecules that bear the LeX
epitope (e.g., Childs et al., 1983; Kannagi et al., 1982;
rusius et al., 1986) and a widespread tissue distribution
Feizi, 1991). In the CNS, mAb FORSE-1 recognizes a high-
olecular-weight chondroitin sulfate proteoglycan (CSPG),
hosphacan (Allendoerfer et al., 1995), whose expression
eaks in the early postnatal brain (Allendoerfer et al., 1995;
ole et al., 1995). A similar early postnatal peak has been
bserved in mouse cerebellum for the large CSPG (astro-
hondrin) recognized by the LeX-binding mAb L5 (Streit et
l., 1990, 1993). In addition, FORSE-1 recognizes several 70-
o 80-kDa proteins in adult cortex, cerebellum, and spinal
ord. LeX is also a component of a number of neutral gly-
olipids in the embryonic rat and mouse cerebral cortex
Allendoerfer et al., 1995; Dasgupta et al., 1996; Yamamoto
et al., 1985) and the P5 and P19 rat cerebellum (Chou et al.,
1996).
The patterns reported by different investigators for anti-
LeX immunostaining vary and sometimes appear contradic-
tory. For example, Mai and Scho¨nlau (1992) report a tran-
sient expression of CD15 in the human fetal lateral
geniculate nucleus (LGN), but our studies show no
FORSE-1 labeling in fetal rat LGN as such. In fact, we
reported that by E15 in rat fetal development, FORSE-1
immunolabeling is restricted to the telencephalon (Tole et
al., 1995). We also did not observe a specialized structure
containing LeX-immunoreactive cells that forms an axon
growth boundary at the optic chiasm, as reported by Marcus
and Mason (1995) for the fetal mouse. In each of the three
studies, the tissue was prepared differently, a different spe-
cies was studied, and a different anti-LeX antibody was
used. These variables make direct comparison between the
results of different investigators difficult.
We first hypothesized that the boundaries delineated by
FORSE-1 immunolabeling in the embryo corresponded to
restrictions in the expression of one or more of the epitope’s
associated carrier protein antigens, most likely the CSPG
(Tole et al., 1995). Upon determining that FORSE-1 recog-
nizes the LeX carbohydrate on phosphacan (Allendoerfer et
al., 1995), we compared the FORSE labeling pattern with
that of phosphacan and investigated which antigens pre-
dominated at the relevant times in development. In the case
of FORSE-1 immunolabeling, the results presented here
indicate that regulation of the epitope takes place at the
carbohydrate level, possibly at the level of glycosyltrans-
ferases that can use lipid acceptor substrates.
MATERIALS AND METHODS
Antibodies and Lectins
FORSE-1 hybridoma supernatant (Tole et al., 1995) was used
ithout dilution in probing immunoblots, tissue sections, and
hin-layer chromatograms (TLCs). FORSE-1 hybridoma cells can be
btained from the Developmental Studies Hybridoma Bank (Iowa
ity, IA). Rabbit polyclonal antiserum to rat phosphacan (Meyer-
uttlitz et al., 1996) was a gift (both to K.L.A. in the P.H.P. lab and
Copyright © 1999 by Academic Press. All rightto Dr. Carol Mason for use by G.A.M.) from Drs. Renee and Richard
Margolis (SUNY Health Science Center, Brooklyn, NY; NYU
Medical Center, New York, NY). SSEA-1 hybridoma supernatant
was a gift from Dr. Jane Dodd (Columbia University, New York,
NY). Anti-CD15 was purchased from Becton–Dickinson (San Jose,
CA). L5 was a gift from Dr. Andrea Streit (Columbia University).
Anti-a(1,3)galactose was a gift from Dr. Jean-Francois Bouhours
(INSERM, Nantes, France). FITC-labeled GSL I-B4 lectin [which
specifically recognizes a(1,3)galactose residues] was purchased
rom Vector Laboratories (Burlingame, CA).
Preparation of Rat Brain Protein Extract
Timed and untimed pregnant Sprague–Dawley rats were ob-
tained from Simonsen Laboratories (Gilroy, CA). The day after
mating is designated E0.5. Collection of tissue followed animal
care and use protocols approved by the Caltech Office of Laboratory
Animal Care in accordance with NIH guidelines. Brains from
embryonic and newborn rats were dissected and homogenized in
PBS plus protease inhibitors as described by Allendoerfer et al.
(1995). The homogenates were centrifuged at 100,000g for 1 h. The
pellet and supernatant from this centrifugation are referred to as
the membrane/cytoskeletal and soluble fractions, respectively.
Protein concentration in these fractions was measured using the
BCA assay (Pierce, Rockford, IL).
SDS–PAGE and Immunoblotting
One-dimensional SDS–polyacrylamide gel electrophoresis and
immunoblots were performed as described (Allendoerfer et al.,
1995; Tole et al., 1995) using either a 6 or 10% resolving gel, a 3%
stacking gel, and overnight transfer to nitrocellulose. Blots were
blocked for 1 h at room temperature in PBS containing 0.05%
ween 20 and 5% nonfat dry milk (Carnation). The blots were
ashed three times in PBS/0.05% Tween 20 and then incubated in
ORSE-1 hybridoma supernatant for 2–5 h at room temperature.
he blots were then washed again in PBS/0.05% Tween 20 and
ncubated with goat anti-mouse IgM affinity-purified antiserum
onjugated to peroxidase (Chemicon, Int.), diluted 1:200.
Lipid Extraction
Glycolipids were extracted from embryonic rat brain using a
modification of the method of Svennerholm and Fredman (1980), as
previously described (Allendoerfer et al., 1995). Tissue was resus-
pended in water and extracted with MeOH and CHCl3. The
ixture was stirred and allowed to separate into upper (aqueous)
nd lower (organic) phases. The two phases were collected, each
as dried down under N2, and material was resuspended in
HCl3/MeOH (1/1) at 2 ml/mg starting tissue.
Lipids were extracted from tissue sections by treatment of these
sections with 100% ethanol for 30 min at room temperature.
Thin-Layer Chromatography
Glycolipids isolated as described above were applied to aluminum-
backed silica 60 high-performance TLC plates (EM Separations,
Gibbstown, NJ) and allowed to dry. TLC was run using the solvent
CHCl3/MeOH/0.02% calcium chloride in H2O (5/4/1) for approxi-
mately 45 min, and the plate was again allowed to dry. For immu-
nostaining, the plate was then dipped in 0.1% polyisobutylmethac-
rylate (PIBM; Aldrich, Milwaukee, WI) in acetone for 90 s and air
s of reproduction in any form reserved.
t
o
s
h
a
(
7
m
r
a
f
a
a
2
s
4
p
M
R
t
1
R
t
d
s
(
p
F
1
a
z
b
w
m
p
m
n
e
o
210 Allendoerfer et al.dried. Plates were then immunostained with FORSE-1 hybridoma
supernatant or L5 mAb diluted 1:200 in PBS/1% BSA as described
in Allendoerfer et al. (1995). For the total glycosphingolipid stain,
he plate was dried after running and then sprayed lightly with an
rcinol solution (0.5 g orcinol dissolved in 100 ml of 3 M aqueous
ulfuric acid, then added slowly to 100 ml of 100% EtOH) and
eated in an oven to 125°C for 5 min.
Immunohistochemistry
FORSE-1 immunostaining of fresh frozen, cryostat-sectioned
tissue was performed after acetone fixation as described in Tole et
l. (1995). For comparison with the results of Mai and Scho¨nlau
1992), tissue was first immersion fixed in Bouin’s fluid [for 105 ml:
5 ml saturated aqueous picric acid, 25 ml formaldehyde (37%), 5
l glacial acetic acid], embedded in paraffin, and sectioned on a
otary microtome. Sections were then deparaffinized, rehydrated in
series of ethanols, and treated with 0.1 M citrate buffer, pH 3.2,
or 5 min for antigen retrieval before being stained with either
nti-CD15 or FORSE-1. For comparison with the results of Marcus
nd Mason (1995), tissue was perfused or immersion fixed in either
or 4% paraformaldehyde in 0.1 M phosphate buffer before being
tained with either SSEA-1 or FORSE-1.
Anti-phosphacan immunostaining was performed on sections of
% paraformaldehyde-immersion-fixed tissue (cortex) or 2%
araformaldehyde-perfused tissue (optic chiasm), as described by
eyer-Puttlitz et al. (1996).
RESULTS
The FORSE-1 Immunolabeling Pattern Is a Subset
of the Phosphacan Immunolabeling Pattern
We have shown previously that FORSE-1 recognizes the
LeX epitope on the brain-specific proteoglycan phosphacan
(Allendoerfer et al., 1995). Phosphacan is present in the
embryonic and postnatal central nervous system, where it
is believed to serve as a modulator of neuronal adhesion and
axon growth (Margolis et al., 1996). The sharp boundaries
observed with FORSE-1 immunostaining in the embryonic
brain could be a consequence of a highly restricted distri-
bution of this carrier protein. FORSE-1 recognizes addi-
tional lower molecular weight glycoproteins in adult tissue,
but these glycoproteins are not present in embryonic tissue
when the boundaries of FORSE-1 labeling are visible (see
Fig. 2A).
To determine whether the restricted pattern of FORSE-1
immunolabeling is a consequence of restricted phosphacan
expression, we compared anti-phosphacan and FORSE-1
immunolabeling in sections of E12 mouse brain and E14 rat
brain. Figures 1A and 1B show the ventral diencephalon in
the area of the optic chiasm in an E12 mouse brain. Here,
FORSE-1 labels a restricted chevron of cells with a nonra-
dial morphology (Fig. 1A). In contrast, anti-phosphacan (Fig.
1B) labels processes radiating out from the third ventricle.
In a separate experiment using adjacent sections of E12
mouse diencephalon, this FORSE-1-immunoreactive array
of cells was shown to correspond to the SSEA-1-
immunoreactive array of cells described in Marcus and
Mason (1995) and Marcus et al. (1995) (G. A. Matthews,
Copyright © 1999 by Academic Press. All right. C. Marcus, and K. L. Allendoerfer, unpublished observa-
ions). Rat diencephalon also exhibits a cluster of FORSE-
/SSEA-1-immunoreactive midline cells (G. A. Matthews,
. C. Marcus, and K. L. Allendoerfer, unpublished observa-
ions).
Figures 1C–1F show adjacent sections of the E14 rat brain
ouble labeled with anti-phosphacan or FORSE-1. These
ections were cut fresh and then fixed with either acetone
for FORSE-1) or 4% paraformaldehyde (for anti-
hosphacan). In the E14 rat brain, as shown in Fig. 1C,
ORSE-1 respects boundaries within the diencephalon (Fig.
C, arrows), whereas anti-phosphacan labels the dienceph-
lon from its dorsal to ventral extent, without sparing the
li (Fig. 1D). As shown in Fig. 1E, FORSE-1 respects a
oundary in the medial wall of the telencephalon (arrow),
hereas anti-phosphacan labels the edge of the medial wall
uch further ventral (Fig. 1F).
Thus, while the FORSE-1 and anti-phosphacan labeling
atterns overlap, the boundaries defined by FORSE-1 im-
unolabeling are not respected by anti-phosphacan immu-
olabeling. It appears, therefore, that in the embryo the LeX
pitope recognized by FORSE-1 is regulated independently
f the proteoglycan to which it is attached.
The FORSE-1/LeX Epitope Is Carried by
Glycolipids in the Embryo and by a Proteoglycan
and Glycoproteins Postnatally
Further evidence that the LeX carbohydrate epitope rec-
ognized by FORSE-1 is regulated independently of the
proteoglycan is found in the developmental expression of
the epitope on its different carrier molecules in the brain.
Figure 2A (a 6% gel) shows the spatial and developmental
expression of the LeX-containing proteoglycan antigen.
This large glycosaminoglycan-rich antigen enters a 6%
resolving gel more easily than a 10% gel and appears as a
wide band in embryonic and postnatal tissue. It is present in
barely detectable amounts in the embryo, although its
expression is enhanced in the forebrain (lane 3) relative to
the rest of the neural tube at this time (lanes 1 and 2). As a
percentage of the total protein, the proteoglycan reaches its
peak in early postnatal life (lane 4). An unidentified proteo-
glycan is visible in smaller amounts in adulthood (lane 5).
We have shown that this band at P1 contains phosphacan,
but have not ruled out the possibility that an additional
FORSE-11 proteoglycan or proteoglycans may have the
same mobility and also be recognized by FORSE-1 in our
blots. The developmental profile of the FORSE-11 proteo-
glycan is consistent with that of FORSE-11 phosphacan,
which is a larger fraction of total forebrain protein at P7
than in the adult (Allendoerfer et al., 1995).
Figure 2B (a 10% gel) shows the appearance of additional
glycoprotein antigens at ,70 kDa in the adult forebrain
(lane 9). This higher percentage gel allows these smaller
glycoproteins to be separated and visualized, whereas in a
6% gel they migrate close to the dye front. These glyco-
protein antigens are not present in the forebrain at E15 or P1
(lanes 7 and 8).
s of reproduction in any form reserved.
A211Lewis-X Patterning in Developing CNSFIG. 1. Anti-phosphacan immunostaining does not respect FORSE-1 labeling boundaries. A 2% paraformaldehyde-fixed horizontal section
of E12 mouse ventral diencephalon was double labeled with FORSE-1 (A) and anti-phosphacan (B). FORSE-1 labels a restricted chevron of
cells at the midline. The posterior boundary of this chevron is marked by arrows. Anti-phosphacan labels a more widespread set of radial
processes. (C–F) Adjacent sections from the E14 rat diencephalon (C, D) and telencephalon (E, F) were stained with FORSE-1 (C, E) or
anti-phosphacan (D, F) under optimal fixation conditions for the antibody in question. The boundaries, marked by arrows, respected by
FORSE-1 immunolabeling, are not respected by anti-phosphacan labeling. Scale bar: A and B, 120 mm; C and D, 750 mm; E and F, 900 mm.bbreviations used: 3, third ventricle; A, anterior; D, dorsal; LV, lateral ventricle; P, posterior; V, ventral.
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212 Allendoerfer et al.In contrast to the protein carriers of LeX, LeX-containing
glycolipids are most strongly expressed at embryonic
stages. FORSE-1-immunoreactive glycolipids are compared
to total glycosphingolipid expression as measured by
orcinol staining in Fig. 3. FORSE-1-immunoreactive neutral
glycolipid antigens are present in detectable amounts only
in embryonic rat forebrain (Fig. 3A, E15 forebrain, lane 7),
whereas they are undetectable in the postnatal and adult
forebrain (Fig. 3A, P1 forebrain, lanes 9 and 10; and adult
forebrain, lanes 11 and 12). Antibody L5, which also recog-
nizes LeX-containing glycoproteins in postnatal and adult
brain (Streit et al., 1990; 1996), recognizes identical glyco-
ipid antigens to FORSE-1 in E15 forebrain (Fig. 3C).
The relatively low abundance of the FORSE-labeled pro-
eoglycan in the embryo and the absence of FORSE-labeled
lycoproteins when domains and sharp boundaries are
resent in the embryo, coupled with the preferential em-
ryonic expression of the glycolipid antigens, suggest that
he glycolipids, not the proteoglycan or glycoproteins, are
argely responsible for the embryonic pattern.
The Distinct Properties of FORSE-1
Immunolabeling in Embryonic vs Postnatal Brain
Are Consistent with Distinct Epitope Carrier
Molecules
To further explore whether the embryonic staining pat-
tern is due primarily to glycolipid antigens, we compared
FIG. 2. Developmental profile of the FORSE-1 immunoreactive
protein antigens. (A) A 6% resolving gel enables the visualization of
the FORSE-1-immunoreactive proteoglycan in embryonic tissue.
The FORSE-1-immunoreactive proteoglycan is present in E15
(lanes 1–3 and 7), P1 (lanes 4 and 8), and adult (lanes 5 and 9)
forebrain, but it reaches its highest levels at P1 (lanes 4 and 8). The
FORSE-1-immunoreactive proteoglycan is enhanced in embryonic
forebrain (lane 3) relative to the spinal cord (lane 1) and the
midbrain/hindbrain (lane 2). Fifty micrograms of protein was
loaded in each lane. (B) A 10% resolving gel enables the visualiza-
tion of additional FORSE-1-immunoreactive glycoproteins in the
adult forebrain (lane 9). These glycoproteins are not present in
embryonic or postnatal forebrain (lanes 7 and 8). Glycoproteins
visible in B are not visible in A because they migrate at or near the
dye front in a 6% gel.the optimum fixation conditions for the embryonic immu- b
Copyright © 1999 by Academic Press. All rightohistochemical staining with those for postnatal sections.
ole et al. (1995) found that the FORSE-1 mAb labels the
elencephalon in sections from E15 rat forebrain best when
hey are freshly cut and subsequently acetone fixed.
ORSE-1 immunostaining is, however, also visible in the
mbryo in 4% paraformaldehyde-fixed sections (Figs. 4A
nd 4C). Figure 4 shows paraformaldehyde-fixed, FORSE-1-
tained sections of the developing mouse hypothalamus at
he level of the optic chiasm at E12 (Fig. 4A) and of the rat
ortex at E14 (Fig. 4C). The chevron of FORSE-1 staining at
he optic chiasm and the stained lateral wall of the telen-
ephalon are visible. This embryonic staining is reduced in
djacent sections by treating them with ethanol for 30 min
t room temperature (Figs. 4B and 4D).
Dehydrating and embedding embryonic tissue for par-
ffin sectioning also result in loss of FORSE-1 labeling, as
ight be expected given the results of 30-min EtOH
xtraction, and this embryonic staining cannot be re-
rieved using the citric acid antigen retrieval technique of
ai and co-workers. For example, FORSE-1 staining of a
resh-frozen, acetone-fixed section from an E15 embryo
Fig. 5A) is compared with a section from an E15 embryo
hat was fixed in Bouin’s fluid, dehydrated with ethanol,
nd then paraffin sectioned before being stained with the
ORSE-1 mAb under citrate antigen retrieval conditions
Fig. 5B). The intense staining observed in the fresh-cut,
cetone-fixed section is completely missing from the
ouin’s-fixed, solvent-extracted, acid-treated section.
he EtOH extractability of the embryonic antigen, its
nhancement with acetone fixation, and the failure of
ntigen retrieval point to the possibility that it is a gly-
olipid antigen.
In contrast to what is observed in the embryo, FORSE-1
mmunostaining in P1 brain is not enhanced by acetone
xation relative to fresh-frozen tissue, and it is virtually
nvisible in aldehyde (either Bouin’s or paraformalde-
yde)-fixed sections that have not undergone citrate an-
igen retrieval (data not shown). Acetone-fixed sections
rom fresh-frozen postnatal brain (Figs. 5C and 5E) are
ompared with sections of cortex from a Bouin’s-fixed,
araffin-embedded, citrate-treated postnatal brain (Figs.
D and 5F). In the postnatal case, the FORSE-1 immuno-
taining of the marginal zone and cortical plate (CP)
ppears enhanced, rather than abolished, by the overall
ldehyde fixation/paraffin/antigen retrieval treatment
elative to acetone treatment. This enhancement of
ORSE-1 staining at P1 is also observed in the thalamus,
here the immunoreactive LGN can be observed under
oth sets of conditions, but more easily after antigen
etrieval.
These differences in optimum conditions for FORSE-1
mmunostaining between embryonic and postnatal tissue
uggest that the LeX epitope is being carried by different
ntigens at the different developmental stages. Enhance-
ent of immunolabeling by acetone fixation and its
bolishment by treatment with EtOH, as is seen in em-
ryonic tissue, is consistent with a neutral glycolipid
s of reproduction in any form reserved.
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213Lewis-X Patterning in Developing CNSantigen; these lipids are soluble in alcohols, but precipi-
tate in acetone (J. Magnani, personal communication). In
the case of proteins, antigen retrieval via acidic pH is
believed to unmask epitopes by denaturing proteins and
breaking down fixation-induced crosslinks in protein an-
tigens (Shi et al., 1994). The success of citrate-based
antigen retrieval at P1, but not E15, is consistent with
a protein antigen in the postnatal tissue. The success-
ful P1 immunostaining after aldehyde fixation, paraf-
fin embedding, and antigen retrieval also shows that
FIG. 3. Developmental profile of FORSE-1-immunoreactive glyc
FORSE-11 proteoglycan, FORSE-11 glycolipids are enhanced in the
tube (mid/hind, midbrain/hindbrain; sp. cord, spinal cord; lanes 3–6
(lanes 9–12). Immunoreactive glycolipids are present in the upper
can also be extracted from the embryo body (lanes 1 and 2 and 13
no primary antibody controls (data not shown). (B) An identical TL
13–24). (C) Two identical TLC plates were run using E15 forebrain
stained with mAb L5 (lanes 27 and 28) or FORSE-1 (lanes 25 and 26).the LeX epitope itself is not destroyed by any of these t
Copyright © 1999 by Academic Press. All rightreatments, including EtOH extraction. The difference in
xation sensitivity also appears to be unrelated to the
nti-LeX Ab used. An identical labeling pattern at both
ges (E15 and P1) under both conditions (acetone and
ouin’s/paraffin) was observed using the commercial
nti-LeX mAb anti-CD15 used by Mai and co-workers
data not shown). Thus, these differences in immunohis-
ochemical properties of the embryonic and postnatal
ntigens suggest corresponding differences in biochemi-
al properties for the antigens carrying the LeX epitope at
ds. (A) A TLC plate is stained with FORSE-1 mAb. As with the
ryonic forebrain (E15 Fb, lane 7) relative to the rest of the neural
ese glycolipids are undetectable in the P1 and adult brain however
ous) phase of the lipid extracts (odd-numbered lanes) only. Lipids
4). Some of these lipids are colored (lane 1) and are also visible in
ate is stained with orcinol to show equal glycolipid loading (lanes
ct (upper phase, lanes 25 and 27; lower phase, lanes 26 and 28) and
e two mAbs recognize identical glycolipid species in E15 forebrain.olipi
emb
). Th
(aque
and 1
C pl
extrahese ages.
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214 Allendoerfer et al.Embryonic Neuropil Does Not Contain
a(1,3)Galactose-Masking Epitopes
In the embryonic brain, the LeX epitope is recognized on the
relatively undifferentiated, dividing cells of the cortical ven-
tricular zone, but not in the intermediate zone and cortical
plate (Tole et al., 1995), which contain more differentiated cell
types, including radial glia and young neurons. The F9 terato-
carcinoma cell line also expresses the LeX epitope in its
FIG. 4. EtOH treatment abolishes FORSE-1 immunolabeling i
diencephalon was stained with FORSE-1. The chevron-shaped clust
adjacent section was treated with 100% EtOH for 30 min at roo
treatment. (C) A section from the E14 rat telencephalon, cut horiz
medial wall is visible (arrow). (D) An adjacent section was treated
treatment. Scale bar for A–D, 700 mm. Abbreviations used: 3, thirdundifferentiated, mitotic state. However, in F9 cells, differen-
Copyright © 1999 by Academic Press. All rightiation induced by retinoic acid (RA) treatment induces the
xpression of an a(1,3)galactosyltransferase, which masks LeX
on the surface of differentiated cells by the addition of
a(1,3)galactose (Cho et al., 1996). It is possible that the
ORSE-12 areas in the brain also arise from an analogous
asking of the LeX epitope in these areas.
We stained embryonic brain sections with fluorescent GSL
-B4 lectin and with an antibody to a(1,3)galactose itself (Fig.
bryonic forebrain. (A) A section from the E12 mouse ventral
cells that form an axon growth boundary is visible (arrows). (B) An
perature before staining. FORSE-1 staining is abolished by this
lly, was stained with FORSE-1. The staining boundary within the
EtOH before staining. FORSE-1 labeling is greatly reduced by this
tricle; A, anterior; LV, lateral ventricle; P, posterior.n em
er of
m tem
onta
with6). Labeling with either of these reagents readily detects
s of reproduction in any form reserved.
te; H
215Lewis-X Patterning in Developing CNSa(1,3)gal-containing glycolipids in pig kidney (Hendricks et
al., 1990; Fig. 6A). Labeling of E12 (Fig. 6B) and E16 (Fig. 6C) rat
forebrain with these reagents, however, yields a detectable
signal only in blood vessels and meninges; the epitope was not
detectable in the neuropil at all. Thus, if the LeX expression
boundaries in rodent brain are the result of epitope masking, it
FIG. 5. FORSE-1 immunostaining cannot be retrieved in E15 b
fresh-frozen section was acetone fixed and immunostained wit
telencephalon is visible (arrow). (B) An E15 Bouin’s fixed, paraffin
immunostained with FORSE-1. The staining in the entire embr
embedding and is not retrieved by citrate treatment. (C, E) P1 fresh
(D, F) P1 Bouin’s fixed, paraffin-embedded, citrate-treated sectio
postnatal FORSE-1 staining relative to what is seen with acetone, ev
Identical results are obtained when adjacent sections are stained wi
plane; scale bar is 1.3 mm. Abbreviations used: CP, cortical pla
geniculate nucleus; LV, lateral ventricle; WM, white matter.is unlikely that the masking sugar is a(1,3)galactose.
Copyright © 1999 by Academic Press. All rightDISCUSSION
The embryonic labeling pattern of the FORSE-1 mAb
defines sharp boundaries in the neural tube, some of which
correspond to boundaries delineated by transcription fac-
tors or respected by growing axons. Consistent with previ-
after paraffin embedding, but it can be in P1 brain. (A) An E15
RSE-1. The staining boundary within the medial wall of the
bedded section was treated with citrate for antigen retrieval and
c telencephalon is abolished by EtOH dehydration and paraffin
n sections were acetone fixed and immunostained with FORSE-1.
ere immunostained with FORSE-1. Antigen retrieval enhances
fter the extensive EtOH extraction required for paraffin embedding.
ti-CD15 mAb (data not shown). All sections are cut in the coronal
, hippocampus; LGE, lateral ganglionic eminence; LGN, lateralrain
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216 Allendoerfer et al.(Canoll et al., 1993; Meyer-Puttlitz et al., 1996; Nishizuka
et al., 1996), we find that the distribution of FORSE-1
FIG. 6. Embryonic neuropil does not contain a(1,3)galactose-
asking epitopes. (A) Section of adult pig kidney is immunostained
ith anti-a(1,3)gal. An adjacent section stained only with second-
ry antibody yielded no labeling (data not shown). (B) An E12 rat
orebrain section is immunostained with anti-a(1,3)gal. Immuno-
taining is visible in meninges (arrow) and blood vessels (arrow-
ead) but not in neuropil. (C) An E16 rat forebrain section is
mmunostained with anti-a(1,3)gal. Immunolabeling is again vis-
ible in meninges (pia; arrow) and blood vessels (arrowhead), but not
in neuropil. Identical results are obtained with the fluorescent
lectin GSL I-B4 (data not shown). C is cut in the coronal plane. Scale
ar: A, 340 mm; B, 880 mm; C, 340 mm. Abbreviations used: CP,
ortical plate; LV, lateral ventricle.abeling in the rodent embryo is more restricted than that of
Copyright © 1999 by Academic Press. All rightnti-phosphacan labeling, which does not respect the same
oundaries.
In the forebrain, the FORSE-1 immunolabeling pattern
onsists of intense, restricted, acetone-enhanced staining in
arly and midgestation embryos, whereas in late gestational
nd postnatal brain the staining observed with acetone
xation becomes weaker and more widespread and is found
hroughout the neocortex and thalamus (Tole et al., 1995).
e show here that postnatal, but not embryonic, staining is
evealed after citrate antigen retrieval when the tissue is
rst fixed with Bouin’s fluid and paraffin embedded. These
ifferent sets of histological findings at the two ages corre-
pond to the expression of two different LeX-carrier anti-
ens at these stages; this developmental profile is summa-
ized in Table 1. The FORSE-1-immunoreactive epitope
eX is carried by antigens that appear in the following
equence: glycolipids predominate early in embryonic de-
elopment, followed by a peak of immunoreactivity on
roteoglycans, including phosphacan, in early postnatal
evelopment, followed by a decrease in the amount of
mmunoreactive proteoglycan and the appearance of lower
olecular weight glycoproteins bearing the epitope in the
dult. Each of these antigens is optimally studied using
ifferent fixation conditions and different biochemical
echniques. This developmental profile mimics that seen
ith the antigens carrying another adhesion-associated
arbohydrate epitope, that recognized by the HNK-1 mAb.
n embryonic and neonatal cerebral cortex, the HNK-1
pitope is a component of sulfoglucuronylglycolipids (SG-
Ls) (Chou et al., 1991), whereas these lipid antigens are
ot detectable in adult forebrain (Jungalwala, 1994). In the
dult, however, the epitope is also present on proteoglycans
including phosphacan: Rauch et al., 1991; Maurel et al.,
994) and integral membrane glycoproteins associated with
ell adhesion (Jungalwala, 1994).
Carbohydrate epitopes may play different roles depending
n whether they are on lipids or proteins. On lipid carrier
olecules they are believed to play direct roles in cell
dhesion, either as agonists for receptors (Varki, 1994) or as
omophilic binding partners (Eggens et al., 1989). Glycolip-
ds have also been shown to anchor larger complexes of
dhesion molecules containing GPI-linked receptors, inte-
rins, and adaptor proteins for signal transduction (Cheresh
t al., 1986; Deckert et al., 1996). Thus, as a glycolipid
omponent early in development, LeX may directly medi-
TABLE 1
Developmental Profile of FORSE-1/LeX-Immunoreactive
Antigens in Rodent CNS
Neutral
glycolipids Proteoglycan
Other
glycoproteins
mbryo 11 1 2
arly postnatal 1 111 2
dult 2 11 1s of reproduction in any form reserved.
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217Lewis-X Patterning in Developing CNSate cellular functions such as adhesion, recognition, and
axon guidance. As a posttranslational modification of a
larger proteoglycan or adhesion glycoprotein later in devel-
opment, a carbohydrate such as LeX would be in a position
to play a more modulatory role.
In the embryonic rodent forebrain, the distribution of LeX
immunolabeling has been compared to the expression pat-
tern of several regulatory genes (Tole and Patterson, 1995;
Marcus et al., 1999). There is a striking overlap between
immunostaining for LeX and BF-1 mRNA expression in the
telencephalon; both label lateral walls of the telencephalic
vesicles, and both respect a common boundary between the
positive and negative areas within the medial wall (Tole
and Patterson, 1995). In addition, Dlx-2 and LeX expres-
ions share several sharp boundaries in the diencephalon,
ncluding the zli (zona limitans intrathalamica), although
they are sometimes present on opposite sides of those
boundaries (Tole and Patterson, 1995). In the ventral dien-
cephalon, LeX-immunoreactive neurons form in a zone
where the edges of the domains of BF-2, Dlx-2, and Nkx-2.2
expression overlap (Marcus et al., 1999). These LeX-
immunoreactive cells then form a boundary along which
early contralaterally projecting retinal axons grow and
which is inhibitory to the growth of ipsilaterally projecting
axons (Mason and Sretavan, 1997).
Since FORSE-1 immunolabeling appears to be regulated
by the expression of the LeX carbohydrate epitope, it will be
of interest to determine how this epitope is synthesized in
the brain. In leukocytes, the final step in the biosynthesis of
LeX is performed by the addition of an a(1,3)fucose residue
o a terminal Galb(1,4)GlcNAc-R (lactoseries) sugar by an
a(1,3)fucosyltransferase (Fuc-T; DeVries and Van den
Eijnden, 1992; Natsuka and Lowe, 1994). The lactoseries
lipid precursor present at high levels in embryonic cerebral
cortex, Galb(1,4)GlcNAcb(1,3)Galb(1,4)Glcb1-Cer (also
called nLcOse4Cer), serves as a common precursor for a
number of glycolipid antigens that do not share the same
spatial distribution as FORSE-1/LeX, including the HNK-1-
reactive SGGLs (Chou and Jungalwala, 1994). With the
nLcOse4Cer precursor being available on LeX-negative cells
and the distribution of phosphacan also being more wide-
spread than that of LeX, it appears that the precise expres-
sion pattern of the LeX epitope in the embryo is not regu-
lated by the availability of the lipid precursor or
proteoglycan carrier molecule. Its expression may instead
be regulated by the activity of one or more glycosyltrans-
ferases that synthesize it, such as a(1,3)Fuc-Ts.
A likely candidate for the a(1,3)Fuc-T activity in brain
tissue is the enzyme known as Fuc-TIV. Sajdel-Sulkowska
et al. (1997) have recently reported the cloning of a rat
Fuc-TIV homologue and expression of its mRNA in adult
rat brain. In addition, Wiederschain et al. (1998) report a
complex pattern of Fuc-TIV-like biochemical activities in
postnatal rat cerebellum. Two mouse Fuc-Ts, mouse Fuc-
TIV (Gersten et al., 1995) and mouse Fuc-TVII (Smith et al.,
1996), have been identified and inactivated by homologous
recombination (Homeister et al., 1996; Maly et al., 1996).
Copyright © 1999 by Academic Press. All rightSurprisingly, FORSE-1 immunostaining of the brains of
the individual and Fuc-TIV/VII double knockout mouse
embryos at E11.5 and E12.5 shows that the staining pattern
is unchanged in the knockouts relative to that in wild-type
mice. This staining pattern in mouse brain, using fresh-cut,
acetone-fixed tissue, is identical to that reported for embry-
onic rat brain at the equivalent developmental stage: in-
tense labeling in the lateral walls of the telencephalon,
restricted domains of labeling in the diencephalon, and
spinal cord labeling restricted to the dorsal half (Allendoer-
fer et al., 1997, and unpublished observations). Moreover, in
immunoblots of P1 forebrain, the high-molecular-weight
proteoglycan can be recognized by FORSE-1 in Fuc-TIV
knockout animals in amounts equivalent to those in wild-
type animals (Allendoerfer et al., 1997). Thus, one or more
additional Fuc-TIV-like enzymes may be present in the
mouse genome. These Fuc-Ts could either be the enzymes
normally responsible for the synthesis of the LeX epitope in
developing forebrain or could take over the function of the
enzyme in the null animals.
Our results suggest that the fucosyltransferase(s) that
synthesize LeX in the developing brain are a part of a
complex mechanism of surface epitope regulation. Expres-
sion of LeX, and any positional information carried by that
epitope, is not conferred directly by transcriptional activa-
tion of a single gene. Instead, the FucT gene or genes
responsible for LeX synthesis in the developing nervous
system are interacting with a developmentally regulated set
of acceptor molecules, in addition to other glycosyltrans-
ferases and glycosidases that may be present in these
tissues. The complex interactions between transcriptional
regulatory genes and glycosyltransferases are just beginning
to be understood. The cell surface carbohydrate recognition
epitopes produced by these glycosyltransferases may pro-
vide an additional mechanism by which differential cell-
surface adhesion and areal identity within the developing
neural tube are established.
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